Alliance Source Testing Revenue and Competitors

Claim your profile

Decatur, AL USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Alliance Source Testing's estimated annual revenue is currently $150.2M per year.(i)
  • Alliance Source Testing received $Undisclosed in venture funding in November 2016.
  • Alliance Source Testing's estimated revenue per employee is $266,700

Employee Data

  • Alliance Source Testing has 563 Employees.(i)
  • Alliance Source Testing grew their employee count by 12% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.8M26-4%N/AN/A
#2
$79.3M30210%N/AN/A
#3
$4M278%N/AN/A
#4
$150.2M56312%N/AN/A
#5
$49M2058%N/AN/A
#6
$106.6M4063%N/AN/A
#7
$3.4M2315%N/AN/A
#8
$10.6M56-2%N/AN/A
#9
$4.3M29-49%N/AN/A
#10
$3286.6M1117932%N/AN/A
Add Company

Alliance Source Testing, LLC Stack Testing Services: Alliance provides investigative and compliance air emissions testing services to industry. From our operations centers in Decatur, AL; Little Rock, AR; Pittsburgh, PA; West Chester, PA; Lewisville, TX; Houston, TX; Salt Lake City, UT; Cedar Rapids, IA; Denver, CO and Anchorage, AK we routinely perform testing projects throughout the entire United States. Oil & Gas Laboratory Services: Alliance provides accurate analytical data for custody transfer analysis, developing emission profiles, design and sizing of vapor control systems, process modeling and site-specific emission factors for permitting and compliance.

keywords:N/A

N/A

Total Funding

563

Number of Employees

$150.2M

Revenue (est)

12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Alliance Source Testing News

2022-04-21 - Ukraine-Russia War News: Updates as Fighting Flares in East

Ukraine Live Updates: Fighting Flares in East, as Russia Issues Warning With Missile Test. President Vladimir Putin said those who threaten...

2022-04-20 - AbbVie ends research alliance on BioArctic Parkinson's drug

BioArctic is also the source of a closely watched Alzheimer's drug called lecanemab that's being developed by Eisai and Biogen.

2022-03-30 - Walgreens shares fall as pandemic demand slows and health-care investments ramp up

Walgreens President John Standley said on the company's earnings call that demand for Covid testing has slowed down since January and February.

2019-09-08 - Trump administration is testing corporate environmental resolve | TheHill

After the 2016 election, however, auto lobbyists, led by the Alliance of Automobile ... 1 source of methane emissions in the U.S. and globally.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$137.5M61110%N/A
#2
$192M76211%N/A
#3
N/A82612%N/A
#4
$392M10377%N/A
#5
$35M1121-25%N/A

Alliance Source Testing Funding

DateAmountRoundLead InvestorsReference
2016-11-30$UndisclosedUndisclosedAlign Capital PartnersArticle